The therapeutic effects of rSj-Cys treatment were associated with the significant reduction of pro-inflammatory cytokines (TNF-α, IL-1β and IL-6) and boost of IL-10 and TGF-β1 cytokines in sera of mice with sepsis. This evidence concerns the gene IL1B and Sepsis.